Statistics for Alliance Pharma PLC (id:3613 APH)
Valuation metrics
Market cap
251.34M
Enterprise value
337.80M
Trailing P/E (ttm)
-750.41
Forward P/E
5.00
PEG ratio
5.00
Price/Sales (ttm)
1.37
Price/Book (mrq)
111.89
Enterprise Value/Revenue
1.84
Enterprise Value/EBITDA
6.56
Overview
Shares outstanding
540.57M
Float
455.53M
Shares short
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
796.13K
Average volume (90 days)
Price summary
52-Week low
24.55
52-Week high
50.26
52-Week change
14.78%
Beta
3.00
50-Day moving average
45.16
200-Day moving average
39.36
Dividends and splits
Forward annual dividend rate
4.74
Forward annual dividend yield
3.00
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
2.18
Payout ratio
0.00
Dividend date
Ex-dividend date
June 22, 2023
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
December 31, 2023
Profitability
Profit margin
-18.34%
Operating margin
17.02%
Operational effectiveness
Return on assets
5.98%
Return on equity
-13.44%
Income statement
Revenue (ttm)
3.00
Revenue per share (ttm)
3.00
Quarterly revenue growth (yoy)
5.00
Gross profit (ttm)
105.02M
EBITDA
50.31M
Net income to common (ttm)
-33,582,000.00
Diluted EPS (ttm)
5.00
Quarterly earnings growth (yoy)
-8.70%
Balance sheet
Total cash (mrq)
19.27M
Total cash per share (mrq)
5.00
Total debt (mrq)
105.79M
Total Debt/Equity (mrq)
47.46
Current ratio (mrq)
293.10%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
30.26M
Levered free cash flow (LFCF)
10.34M